ESG Report

Overview

The report presents SK bioscience's first ESG disclosure, covering 2021 performance and activities across environmental, social, and governance topics. The company established an ESG Committee under the Board and describes Board-led oversight of ESG management. It reports 2021 greenhouse-gas emissions of 16,927 tCO2-eq and energy consumption of 347.5 TJ. Social highlights include workforce growth to 1,007 employees, a 37% female-employee ratio, and continued investment in vaccine R&D and global public-health partnerships.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2021
Period: 1 January 2021 – 31 December 2021
Publication date: 1 June 2022
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services